Evidence map›Paper›PMID 36871883›Full record

ArticleNeuroscience2023

Striatal Subregion-selective Dysregulated Dopamine Receptor-mediated Intracellular Signaling in a Model of DOPA-responsive Dystonia.

Kaitlyn M Roman, Maria A Briscione, Yuping Donsante, Jordan Ingram, Xueliang Fan, Douglas Bernhard, Simone A Campbell, Anthony M Downs, David Gutman, Tejas A Sardar and 4 more

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Kaitlyn M RomanDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
Maria A BriscioneDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
Yuping DonsanteDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
Jordan IngramDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
Xueliang FanDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
Douglas BernhardDepartment of Neurology, Emory University, Atlanta, GA, USA.
Simone A CampbellDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
Anthony M DownsDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
David GutmanDepartment of Biomedical Informatics, Emory University, Atlanta, GA, USA.
Tejas A SardarDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
Sofia Q BonnoDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA.
Diane J SutcliffeDepartment of Neurology, Emory University, Atlanta, GA, USA.
H A JinnahDepartment of Neurology, Emory University, Atlanta, GA, USA; Department of Human Genetics, Emory University, Atlanta, GA, USA; Department of Pediatrics, Emory University, Atlanta, GA, USA.
Ellen J HessDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, USA; Department of Neurology, Emory University, Atlanta, GA, USA. Electronic address: ellen.hess@emory.edu.
Emory University · US

Funding

Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGYT32NS007480 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2000 to 2020
$4.5M
Neuronal Mechanisms Underlying Sex Differences in DystoniaR01NS124764 · NINDS · EMORY UNIVERSITY · PI HESS, ELLEN J. · 2022 to 2025
$2.1M
Dopamine neurotransmission in a model of DOPA-responsive dystoniaR01NS088528 · NINDS · EMORY UNIVERSITY · PI HESS, ELLEN J. · 2015 to 2019
$1.9M
Neuronal mechanisms underlying sex differences in dystoniaR56NS124764 · NINDS · EMORY UNIVERSITY · PI HESS, ELLEN J. · 2021 to 2021
$539k
Selective muscarinic receptor antagonists as therapeutics in dystoniaF31NS103363 · NINDS · EMORY UNIVERSITY · PI DOWNS, ANTHONY M · 2018 to 2020
$135k
NIGMS NIH HHS T32 GM008602NINDS NIH HHS F31 NS103363NINDS NIH HHS R01 NS088528NINDS NIH HHS R01 NS124764NINDS NIH HHS R56 NS124764NINDS NIH HHS T32 NS007480
6 · The paper itself

Abstract

Although the mechanisms underlying dystonia are largely unknown, dystonia is often associated with abnormal dopamine neurotransmission. DOPA-responsive dystonia (DRD) is a prototype disorder for understanding dopamine dysfunction in dystonia because it is caused by mutations in genes necessary for the synthesis of dopamine and alleviated by the indirect-acting dopamine agonist l-DOPA. Although adaptations in striatal dopamine receptor-mediated intracellular signaling have been studied extensively in models of Parkinson's disease, another movement disorders associated with dopamine deficiency, little is known about dopaminergic adaptations in dystonia. To identify the dopamine receptor-mediated intracellular signaling associated with dystonia, we used immunohistochemistry to quantify striatal protein kinase A activity and extracellular signal-related kinase (ERK) phosphorylation after dopaminergic challenges in a knockin mouse model of DRD. l-DOPA treatment induced the phosphorylation of both protein kinase A substrates and ERK largely in D1 dopamine receptor-expressing striatal neurons. As expected, this response was blocked by pretreatment with the D1 dopamine receptor antagonist SCH23390. The D2 dopamine receptor antagonist raclopride also significantly reduced the phosphorylation of ERK; this contrasts with models of parkinsonism in which l-DOPA-induced ERK phosphorylation is not mediated by D2 dopamine receptors. Further, the dysregulated signaling was dependent on striatal subdomains whereby ERK phosphorylation was largely confined to dorsomedial (associative) striatum while the dorsolateral (sensorimotor) striatum was unresponsive. This complex interaction between striatal functional domains and dysregulated dopamine-receptor mediated responses has not been observed in other models of dopamine deficiency, such as parkinsonism, suggesting that regional variation in dopamine-mediated neurotransmission may be a hallmark of dystonia.

Indexed as

DystoniaParkinsonian DisordersAnimalsCorpus StriatumDopamineDopamine AntagonistsDystonic DisordersExtracellular Signal-Regulated MAP KinasesLevodopaMiceReceptors, Dopamine D1DopamineDopamine AntagonistsExtracellular Signal-Regulated MAP KinasesLevodopaReceptors, Dopamine D1dopaminedystoniaextracellular signal-related kinaseprotein kinase Astriatum

Identifiers

PMID36871883
PMCPMC10085842
OpenAlexW4323031078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.